Stay updated with breaking news from Keyes Plant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Aemetis, Inc. (NASDAQ:AMTX – Get Rating) have been given an average rating of “Hold” by the six research firms that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation and one has issued a buy recommendation on […]
Our Management's Discussion and Analysis of Financial Condition and Results of Operations is provided in addition to the accompanying consolidated condensed financial statements and notes to assist... | August 8, 2022
Equities analysts predict that Aemetis, Inc. (NASDAQ:AMTX – Get Rating) will post earnings of ($0.35) per share for the current quarter, Zacks reports. Three analysts have issued estimates for Aemetis’ earnings, with the lowest EPS estimate coming in at ($0.38) and the highest estimate coming in at ($0.32). Aemetis reported earnings of ($0.69) per share […]
Aemetis (NASDAQ:AMTX – Get Rating) posted its earnings results on Thursday. The specialty chemicals company reported ($0.03) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.26) by $0.23, Fidelity Earnings reports. During the same period last year, the business posted ($0.68) EPS. Shares of AMTX traded down $0.80 during […]
Wall Street analysts expect that Aemetis, Inc. (NASDAQ:AMTX – Get Rating) will post $55.87 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Aemetis’ earnings. The highest sales estimate is $61.00 million and the lowest is $49.00 million. Aemetis posted sales of $37.33 million during the same quarter […]